Individual stockholders are not controlling this price range. the Wavering price is benefiting the bigger traders and will continue past the next earnings announcement. Walgreens is playing to the 1% of holders with buy backs and dividend increases, However the price is floundering in the low 30's as its competitor are eating Wags Rxs, and that's not Sushi.
Noticing Walgreens executives future, well that vote was cast in the Annual meeting, so I don't see anything changing on that Front.
Should the Esrx/MHS merger be approved the low 20' are a excellent projection.